Search

everythinglearnresearchcommunity

for

Search:↓

Higher CRP levels suggest chronic inflammation is linked to bladder-related urinary symptoms in men with enlarged prostates.

Early balding may be a sign of future prostate problems.

Urinary PSA could be an early marker for enlarged prostate.

Biofeedback treatment for dysfunctional voiding in adults showed no symptom improvement.

PSA testing is a reliable method for detecting prostate cancer, and opioids may lower PSA levels, but triglycerides don't affect prostate cancer risk.

After prostate removal surgery, higher initial prostate size was linked to higher urethral PSA levels and more severe male pattern baldness.

Low dose finasteride causes only small changes in PSA levels in older men with BPH.

Shorter PSADT after prostate surgery is linked to higher risk of death.

Finasteride for hair loss lowers PSA levels, so PSA values need adjusting when screening for prostate cancer.

Finasteride lowers PSA levels in men, certain factors increase testicular cancer risk, and current guidelines for penile cancer may lead to unnecessary surgeries.

Finasteride lowers PSA levels about the same whether taken at 1 mg or 5 mg daily.

Finasteride helps increase or maintain hair in most men but can cause sexual side effects and should not be used by women, especially during pregnancy.

Canine hypothyroidism can be linked to diabetes, requiring thorough testing for proper diagnosis.

Finasteride is effective for male hair loss, but it may cause fertility issues, mental health problems, and rarely, breast growth. Regular health checks can reduce the risk of prostate cancer. Patient understanding and involvement in treatment is important.

There is no link between hair loss and prostate enlargement.

Early hair loss in men could be a sign of non-cancerous prostate enlargement, and treating hair loss early might help prevent prostate issues later.

Hair loss can be an early sign of prostate enlargement.

Large prostate patients more likely to have hair loss.

Researchers created five new human scalp cell lines that could be useful for hair growth and loss research.

Foxp3+ Regulatory T Cells are important for immunity and tolerance, affect hair growth and wound healing, and their dysfunction can contribute to obesity-related diseases and other health issues.

The MAGE3 hypothesis for alopecia areata did not lead to a significant breakthrough.

Using a single PSA level to decide on a prostate biopsy is not effective; a more personalized approach considering various factors is recommended.

Androgen deprivation therapy for prostate cancer can cause sexual, physical, and psychological side effects, and doctors should manage these carefully.

A new vaccine using a porous scaffold boosts immunity and protects against the flu better than traditional methods.

Dutasteride is more effective than Finasteride in reducing prostate size and PSA levels, but both drugs have similar side effects.

Finasteride improves prostate cancer detection in PSA test.

Anti-Desmocollin 3 antibodies can cause pemphigus-like symptoms in mice.

Scientists created cell lines from balding patients and found that cells from the front of the scalp are more affected by hormones that cause hair loss than those from the back.

Inflammation in hair follicles is a key risk factor for developing common baldness.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.